These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23807675)

  • 21. XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies.
    Wu K; Su D; Lin K; Luo J; Au WW
    Asian Pac J Cancer Prev; 2011; 12(9):2237-43. PubMed ID: 22296363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement.
    Li DJ; Xiao D
    BMC Cancer; 2017 Jul; 17(1):501. PubMed ID: 28743242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis.
    Liu DY; Liang HC; Xiao XM
    Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk.
    Wang YD; Zhai WL; Wang HY; Xia XQ
    Asian Pac J Cancer Prev; 2014; 15(11):4443-8. PubMed ID: 24969866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
    Duell EJ; Holly EA; Bracci PM; Wiencke JK; Kelsey KT
    Cancer Res; 2002 Aug; 62(16):4630-6. PubMed ID: 12183419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis of associations between XRCC1 gene polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis.
    Zhang MY; Yang XK; Lv TT; Wu J; Xu SZ; Wang JB; Pan HF; Ye DQ
    Int J Rheum Dis; 2018 Jan; 21(1):179-185. PubMed ID: 28198159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.
    Huang Y; Xie D; Tang N; Wang J; Zeng X; Zhao P; He L
    Tumour Biol; 2014 Jan; 35(1):799-808. PubMed ID: 23990457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reappraisal of XRCC1 Arg194Trp polymorphism and glioma risk: a cumulative meta-analysis.
    Lu JT; Deng AP; Song J; Zhang L; Luo J
    Oncotarget; 2017 Mar; 8(13):21599-21608. PubMed ID: 28423490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between DNA repair genes (XPD and XRCC1) polymorphisms and susceptibility to age-related cataract (ARC): a meta-analysis.
    Zheng LR; Ma JJ; Zhou DX; An LF; Zhang YQ
    Graefes Arch Clin Exp Ophthalmol; 2014 Aug; 252(8):1259-66. PubMed ID: 24906341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. XRCC1 polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
    Hu Z; Hu X; Long J; Su L; Wei B
    Gene; 2013 Oct; 528(2):67-73. PubMed ID: 23872202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
    Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
    PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA repair genes XRCC1 and ERCC1 polymorphisms and the risk of sporadic breast cancer in Han women in the Gansu Province of China.
    Zhu G; Wang L; Guo H; Lu L; Yang S; Wang T; Guo H; Wang H; Min J; Yang K; Chen X; Liu Y; Wang Z; Su H
    Genet Test Mol Biomarkers; 2015 Jul; 19(7):387-93. PubMed ID: 25961110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease.
    Trabulus S; Guven GS; Altiparmak MR; Batar B; Tun O; Yalin AS; Tunckale A; Guven M
    Mol Biol Rep; 2012 Jun; 39(6):6995-7001. PubMed ID: 22302399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of X-ray repair cross-complementing group 1 promoter rs3213245 polymorphism with lung cancer risk.
    Wang R; Zhang Y; Zhang J; Zhi X
    Tumour Biol; 2014 Mar; 35(3):1739-43. PubMed ID: 24470137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between X-ray repair cross-complementing group 1 Arg194Trp polymorphism and prostate cancer risk.
    He F; Li G; Man L; Liu N
    Tumour Biol; 2014 May; 35(5):4041-5. PubMed ID: 24492938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.
    Qi Y; Cui L; Song Y; Li N
    Mol Biol Rep; 2014 Feb; 41(2):879-87. PubMed ID: 24390232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms of DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln), and the risk of age-related cataract: a meta-analysis.
    Liu XC; Liu XF; Hu ZD; Li ZH
    Curr Eye Res; 2015 Jul; 40(7):676-82. PubMed ID: 25285569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis.
    Cui Z; Yin Z; Li X; Wu W; Guan P; Zhou B
    BMC Cancer; 2012 Feb; 12():71. PubMed ID: 22339849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between the XRCC1 Arg399Gln polymorphism and risk of cancer: evidence from 297 case-control studies.
    Yi L; Xiao-Feng H; Yun-Tao L; Hao L; Ye S; Song-Tao Q
    PLoS One; 2013; 8(10):e78071. PubMed ID: 24205095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of XRCC1 gene polymorphisms and pancreatic cancer risk in a Chinese population.
    Wang LJ; Wang HT; Wang XX
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.